Prestige Consumer Healthcare
PBH
#3949
Rank
HK$23.09 B
Marketcap
HK$469.17
Share price
-0.84%
Change (1 day)
-27.59%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): HK$31.63

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$31.58. In 2024 the company made an earnings per share (EPS) of HK$33.45 an increase over its 2023 EPS that were of -HK$12.52.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$31.63-5.43%
2024HK$33.45-367.08%
2023-HK$12.52-138.33%
2022HK$32.6711.7%
2021HK$29.2513.6%
2020HK$25.75-651.67%
2019-HK$4.67-148.78%
2018HK$9.57-83.29%
2017HK$57.26437.23%
2016HK$10.66-34.13%
2015HK$16.1852.94%
2014HK$10.58-8.11%
2013HK$11.51
2011HK$6.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
HK$27.97-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$13.38-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
-HK$230.43-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.21 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.49-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$57.26 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
HK$54.69 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$3.11-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$49.87 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.68 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA